The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa

New TB vaccine candidates need to be assessed in clinical trials in countries with high rates of TB in the coming years.An open-access directory of TB vaccine clinical trial centres in sub-Saharan Africa was established, providing an overview of the capacity to conduct clinical trials for TB vaccine candidates (http://www.edctp.org/our-work/coordination-tb-vaccine-funded-research/directory-tb-vaccine-clinical-trial-sites-sub-saharan-africa/).The directory is intended for clinical triallists, funders, policymakers, and researchers to accelerate the clinical development of novel TB vaccines by providing useful information.Regular updates are necessary to ensure the directory remains relevant for vaccine development and feeds into the continental Clinical Trials Community (https://ctc.africa/).

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-10-28
DOI
https://doi.org/10.1371/journal.pone.0292981
Citations
1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa

Marit Holleman, Thomas Nyirenda, Job van Rest, Puck T. Pelzer et al.
1 citations
PLoS ONE
Tuberculosis Research and Epidemiology
0.39
article

The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa

Marit Holleman, Thomas Nyirenda, Job van Rest, Puck T. Pelzer, Michelle E. H. Helinski, Pauline Beattie, Gérald Voss, Ana Lúcia Weinberg, Joeri S. Buis
article en
1 citations

Abstract

New TB vaccine candidates need to be assessed in clinical trials in countries with high rates of TB in the coming years.An open-access directory of TB vaccine clinical trial centres in sub-Saharan Africa was established, providing an overview of the capacity to conduct clinical trials for TB vaccine candidates (http://www.edctp.org/our-work/coordination-tb-vaccine-funded-research/directory-tb-vaccine-clinical-trial-sites-sub-saharan-africa/).The directory is intended for clinical triallists, funders, policymakers, and researchers to accelerate the clinical development of novel TB vaccines by providing useful information.Regular updates are necessary to ensure the directory remains relevant for vaccine development and feeds into the continental Clinical Trials Community (https://ctc.africa/).

PLoS ONEVol. 19(10)
TuBerculosis Vaccine Initiative (NL), London School of Hygiene & Tropical Medicine (GB), Amsterdam Institute for Global Health and Development (NL), European & Developing Countries Clinical Trials Partnership (NL)
European and Developing Countries Clinical Trials Partnership
Partnerships for the goals
Openalex Percentile: Top 35%
Tuberculosis Research and Epidemiology
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa — Marit Holleman, Thomas Nyirenda, et al. · PLoS ONE (2024) | TGRS Research Map | TGRS